AU2001272421A1 - Full length human hcn1 ih channel subunit and variants - Google Patents

Full length human hcn1 ih channel subunit and variants

Info

Publication number
AU2001272421A1
AU2001272421A1 AU2001272421A AU7242101A AU2001272421A1 AU 2001272421 A1 AU2001272421 A1 AU 2001272421A1 AU 2001272421 A AU2001272421 A AU 2001272421A AU 7242101 A AU7242101 A AU 7242101A AU 2001272421 A1 AU2001272421 A1 AU 2001272421A1
Authority
AU
Australia
Prior art keywords
variants
full length
length human
channel subunit
human hcn1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001272421A
Inventor
Donald Robert Dunbar
John Anthony Morrow
Deborah Grace Tolan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU2001272421A1 publication Critical patent/AU2001272421A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001272421A 2000-05-24 2001-05-22 Full length human hcn1 ih channel subunit and variants Abandoned AU2001272421A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP00304420 2000-05-24
EP00304420.3 2000-05-24
EP01201344.7 2001-04-12
EP01201344 2001-04-12
PCT/EP2001/005959 WO2001090142A2 (en) 2000-05-24 2001-05-22 FULL LENGTH HUMAN HCN1 Ih CHANNEL SUBUNIT AND VARIANTS

Publications (1)

Publication Number Publication Date
AU2001272421A1 true AU2001272421A1 (en) 2001-12-03

Family

ID=26073171

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001272421A Abandoned AU2001272421A1 (en) 2000-05-24 2001-05-22 Full length human hcn1 ih channel subunit and variants

Country Status (4)

Country Link
US (1) US7329510B2 (en)
EP (1) EP1297136A2 (en)
AU (1) AU2001272421A1 (en)
WO (1) WO2001090142A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050014141A1 (en) * 2001-01-23 2005-01-20 Folander Kimberly L. Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn1
TW201022233A (en) * 2008-11-04 2010-06-16 Organon Nv (Pyrrolidin-2-yl)phenyl derivatives
TW201105324A (en) 2009-07-07 2011-02-16 Organon Nv 2-(1,2-benzisoxazol-3-yl)benzylamine derivatives
BR112012015170A8 (en) 2009-12-22 2017-12-26 Msd Oss Bv AMINOHETEROARYL DERIVATIVE, PHARMACEUTICAL COMPOSITION, USE OF AN AMINOHETEROARYL DERIVATIVE, AND METHOD FOR TREATMENT OF PAIN

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6703485B2 (en) 1997-12-23 2004-03-09 The Trustees Of Columbia University In The City Of New York Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof
EP1309624A2 (en) 2000-07-03 2003-05-14 Smithkline Beecham Plc Hcn polypeptides and polynukleotides and their use in therapy

Also Published As

Publication number Publication date
EP1297136A2 (en) 2003-04-02
WO2001090142A3 (en) 2002-12-05
WO2001090142A2 (en) 2001-11-29
US20030180753A1 (en) 2003-09-25
US7329510B2 (en) 2008-02-12

Similar Documents

Publication Publication Date Title
AU2001292297A1 (en) Mouthpiece for orthodontic treatment and device for orthodontic treatment using the mouthpiece
AU2001280455A1 (en) Therapeutic device and system
AU2002241538A1 (en) Intrasvascular drug delivery device and use therefor
AU8918901A (en) Scleral clip and procedures for using same
AU2001258260A1 (en) Disposable external fixation device
AU9683901A (en) Novel human beta2 integrin alpha subunit
AU2001213042A1 (en) Kneading device and forming device
AU3375299A (en) Human telomerase catayltic subunit variants
AU2001290063A1 (en) Time keeping system and watch
MXPA02003174A (en) Novel combination of loteprednol and antihistamines.
AU2001256325A1 (en) Human and humanized fap-alpha-specific antibodies
GB0020532D0 (en) Channel member
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002210916A1 (en) Endoscope attachment and endoscope
AU2002227925A1 (en) Human beta-defensin-3
AU2001271455A1 (en) A human calcium channel protein and uses thereof
AU2001272421A1 (en) Full length human hcn1 ih channel subunit and variants
AU2001277980A1 (en) Human cytokine receptor
AU2001273070A1 (en) Secretion and trafficking molecules
AU2002233947A1 (en) Hand held spectator timing and scoring monitor system
EP1224265A4 (en) Novel human potassium channel subunit
EP1395602A4 (en) Novel human potassium channel beta subunit
AU2001261320A1 (en) Improved light-generating and beam-establishing device
EP1517917A4 (en) Human erg2 potassium channel